UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

JACC. Heart failure, 2015-06, Vol.3 (6), p.487-496

2015

Volltextzugriff (PDF)

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

Journal of the American Society of Hypertension, 2012-03, Vol.6 (2), p.152-158

2012

Volltextzugriff (PDF)

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

European journal of heart failure, 2015-10, Vol.17 (10), p.1066-1074

2015

Volltextzugriff (PDF)

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease

International journal of cardiology, 2018-09, Vol.266, p.187-192

2018

Volltextzugriff (PDF)

An Exploratory Propensity-Score Matched Comparison of Second-Generation and First-Generation Baroreflex Activation Therapy Systems

Journal of the American Society of Hypertension, 2017-02, Vol.11 (2), p.81-91

2017

Volltextzugriff (PDF)

Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling

Circulation (New York, N.Y.), 2002-03, Vol.105 (11), p.1304-1310

2002

Volltextzugriff (PDF)

Septal to Posterior Wall Motion Delay Fails to Predict Reverse Remodeling or Clinical Improvement in Patients Undergoing Cardiac Resynchronization Therapy

Journal of the American College of Cardiology, 2005-12, Vol.46 (12), p.2208-2214

2005

Volltextzugriff (PDF)

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

Seminars in thoracic and cardiovascular surgery, 2016, Vol.28 (2), p.320-328

2016

Volltextzugriff (PDF)

BAROREFLEX ACTIVATION THERAPY PROVIDES DURABLE BENEFIT IN PATIENTS WITH RESISTANT HYPERTENSION: LONG-TERM FOLLOW-UP RESULTS FROM THE RHEOS PIVOTAL TRIAL

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E1730-E1730

2012

Volltextzugriff (PDF)

Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension: Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial

Journal of the American College of Cardiology, 2011-08, Vol.58 (7), p.765-773

2011

Volltextzugriff (PDF)

Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

Journal of the American College of Cardiology, 2011-08, Vol.58 (7), p.765-773

2011

Volltextzugriff (PDF)

Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy : A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing

Circulation (New York, N.Y.), 2007-04, Vol.115 (16), p.2136-2144

2007

Volltextzugriff (PDF)

MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL

Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E1784-E1784

2012

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2012-01, Vol.59 (5), p.541

2012

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2012-01, Vol.59 (5), p.541-542

2012

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2012, Vol.59 (5), p.541-542

2012

Volltextzugriff (PDF)

SDANN as a Predictor of Heart Failure Hospitalizations in Cardiac Resynchronization Therapy Patients

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S112-S113

2006

Volltextzugriff (PDF)

Can Patients with LVEF > 35% Improve with Cardiac Resynchronization?

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S79-S79

2006

Volltextzugriff (PDF)

Response to Letter Regarding Article, “Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing”

Circulation (New York, N.Y.), 2008-01, Vol.117 (3)

2008

Volltextzugriff (PDF)

1059-19 Effect of cardiac resynchronization therapy in patients with right bundle branch block

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A14-A14

2004

Volltextzugriff (PDF)

Dyssynchrony, Left Ventricular Size, and Gender Predict Echocardiographic Response to Cardiac Resynchronization Therapy in the DECREASE-HF Study

Journal of cardiac failure, 2007, Vol.13 (6), p.S137-S138

2007

Volltextzugriff (PDF)

AB48-1

Heart rhythm, 2006-05, Vol.3 (5), p.S99

2006

Volltextzugriff (PDF)

What Risks Are Associated with Cardiopulmonary Exercise Testing in Cardiac Resynchronization Therapy Studies?

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S76-S76

2006

Volltextzugriff (PDF)

Assessment of Different Cardiac Resynchronization Therapies Utilizing O2 Pulse

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S48

2006

Volltextzugriff (PDF)

The Effect of Three Biventricular Pacing Methods on HRV and SDANN Measurements

Journal of cardiac failure, 2006-08, Vol.12 (6), p.S114-S114

2006

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

Baroreflex Activation Therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease

An Exploratory Propensity-Score Matched Comparison of Second-Generation and First-Generation Baroreflex Activation Therapy Systems

Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling

Septal to Posterior Wall Motion Delay Fails to Predict Reverse Remodeling or Clinical Improvement in Patients Undergoing Cardiac Resynchronization Therapy

Surgical Experience and Long-Term Results of Baroreflex Activation Therapy for Heart Failure with Reduced Ejection Fraction

BAROREFLEX ACTIVATION THERAPY PROVIDES DURABLE BENEFIT IN PATIENTS WITH RESISTANT HYPERTENSION: LONG-TERM FOLLOW-UP RESULTS FROM THE RHEOS PIVOTAL TRIAL

Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension: Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial

Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension

Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy : A randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing

MINIMALLY-INVASIVE SYSTEM FOR BAROREFLEX ACTIVATION THERAPY CHRONICALLY REDUCES BLOOD PRESSURE: INITIAL RESULTS FROM THE BAROSTIM NEO TRIAL

Reply

Reply

Reply

SDANN as a Predictor of Heart Failure Hospitalizations in Cardiac Resynchronization Therapy Patients

Can Patients with LVEF > 35% Improve with Cardiac Resynchronization?

Response to Letter Regarding Article, “Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing”

1059-19 Effect of cardiac resynchronization therapy in patients with right bundle branch block

Dyssynchrony, Left Ventricular Size, and Gender Predict Echocardiographic Response to Cardiac Resynchronization Therapy in the DECREASE-HF Study

AB48-1

What Risks Are Associated with Cardiopulmonary Exercise Testing in Cardiac Resynchronization Therapy Studies?

Assessment of Different Cardiac Resynchronization Therapies Utilizing O2 Pulse

The Effect of Three Biventricular Pacing Methods on HRV and SDANN Measurements

Suchergebnisse filtern